Home LiteratureArticle Details
PMID: 8878389 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.

Transplantation ·Vol. 62 ·No. 7 ·1996-10-15 ·Pages 947-53

Schwaighofer H, Kernan NA, O'Reilly RJ, Brankova J, Nachbaur D, Herold M, Eibl B, Niederwieser D

Abstract

Cytokines are increasingly recognized as important mediators of graft-versus-host disease (GVHD). Measurements of cytokine serum levels in patients with GVHD, and successful prevention and treatment of the disease with the use of cytokine antagonists to either the cytokine or its receptor, are only two of several factors demonstrating the involvement of cytokines in GVHD. To further investigate the role of cytokines in the pathomechanism of acute GVHD, we investigated endogenous serum levels of various cytokines and dependent molecules in sera of 14 patients after T-cell-depleted (TCD) bone marrow transplantation (BMT) and compared the results with those of 12 patients undergoing non-TCD BMT. The effect of various conditioning regimens and of hematopoietic reconstitution on cytokine serum levels was analyzed in detail in these cohorts of patients by measuring interferon (IFN)-gamma, IFN-alpha, tumor necrosis factor-alpha, interleukin-6, neopterin, and beta2-microglobulin. The analyses showed that an increase in IFN-gamma and neopterin serum levels was a specific feature of cyclophosphamide administration and was not observed after other cytostatic drugs or total body irradiation, and that an increase in IFN-gamma, neopterin, beta2-microglobulin, and IFN-alpha release depends on the presence of T cells in the graft. We conclude that significant cytokine serum alterations were noted after TCD BMT as compared with after non-TCD BMT. These alterations, besides depletion of cytotoxic effector cells, might be involved in preventing GVHD after TCD BMT. In addition, more attention should be devoted to the cytokine release-inducing capacity of the conditioning regimen, because such a release might influence the occurrence of transplant-related complications after BMT.

MeSH Terms
Animals Biopterin/analogs & derivatives,blood Bone Marrow Cells Bone Marrow Purging Bone Marrow Transplantation Cytokines/biosynthesis,blood Hematopoietic Stem Cells/cytology Humans Lymphocyte Depletion Mice Neopterin Rabbits Second Messenger Systems/physiology T-Lymphocytes/cytology,metabolism,physiology
Chemicals
Cytokines Biopterin Neopterin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Schwaighofer H
Department of Internal Medicine, Innsbruck University Hospital, Austria.
Kernan N A
O'Reilly R J
Brankova J
Nachbaur D
Herold M
Eibl B
Niederwieser D
Article Info
Journal
Transplantation
Abbr.
Transplantation
ISSN
0041-1337
Published
1996-10-15
Pages
947-53
Language
English
Region
United States
NLM ID
0132144
Subset
IM
Grants
NCI NIH HHS · CA23766 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com